Job title

Principal Global Medical Science Director

Company

Roche-Genentech

2025 Ophthalmology Futures Forums participation

Retina Forum, Paris 2025

11:20 - 11:50

Panel 3: Neovascular AMD: Are the Novel Extended Interval Therapies Truly Making a Difference?